Brief: Innovative Pharmaceutical Biotech Posts HY Profit Attributable Of HK$125.1 Million
Nov 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* HY REVENUE HK$6.6 MILLION VERSUS HK$7.2 MILLION
* HY PROFIT ATTRIBUTABLE HK$125.1 MILLION VERSUS LOSS OF
HK$93.4
MILLION
Source text for Eikon: ID:nHKS3mzsrN
Further company coverage: 0399.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU